Lifeward (LFWD) Share-based Compensation (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.99% |
| Dec 31, 2025 | -4.02% |
| Sep 30, 2025 | -4.40% |
| Jun 30, 2025 | -17.27% |
| Mar 31, 2025 | -5.98% |
| Dec 31, 2024 | -19.31% |
| Sep 30, 2024 | -22.87% |
| Jun 30, 2024 | -1.31% |
| Mar 31, 2024 | 2.14% |
| Dec 31, 2023 | 12.01% |
| Sep 30, 2023 | 4.72% |
| Jun 30, 2023 | 4.61% |
| Mar 31, 2023 | -12.39% |
| Dec 31, 2022 | 8.44% |
| Sep 30, 2022 | 84.97% |
| Jun 30, 2022 | 13.07% |
| Mar 31, 2022 | -34.62% |
| Dec 31, 2021 | 1.30% |
| Sep 30, 2021 | 15.50% |
| Jun 30, 2021 | 19.05% |
| Mar 31, 2021 | -18.05% |
| Dec 31, 2020 | -11.64% |
| Sep 30, 2020 | 105.31% |
| Jun 30, 2020 | -43.22% |
| Mar 31, 2020 | -16.74% |
| Dec 31, 2019 | 1.27% |
| Sep 30, 2019 | -24.84% |
| Jun 30, 2019 | -1.57% |
| Mar 31, 2019 | -24.76% |
| Dec 31, 2018 | -18.93% |
| Sep 30, 2018 | -48.88% |
| Jun 30, 2018 | 28.52% |
| Mar 31, 2018 | -24.69% |
| Dec 31, 2017 | 17.58% |
| Sep 30, 2017 | 6.14% |
| Jun 30, 2017 | -0.47% |
| Mar 31, 2017 | -9.47% |
| Dec 31, 2016 | 2.73% |
| Sep 30, 2016 | 10.77% |
| Jun 30, 2016 | 15.20% |
| Mar 31, 2016 | 8.47% |
| Dec 31, 2015 | 28.85% |
| Sep 30, 2015 | -12.31% |
| Jun 30, 2015 | -0.17% |
| Mar 31, 2015 | 102.77% |